ASX Closes Higher; Neuren Pharmaceuticals and DroneShield Lead Gains

April 14, 2025 06:27 PM AEST | By Team Kalkine Media
 ASX Closes Higher; Neuren Pharmaceuticals and DroneShield Lead Gains

Highlights:

  • Australian sharemarket finished higher, supported by broader strength across Asian equities and US futures

  • Technology sector led the gains, advancing the most among all sectors

  • Neuren Pharmaceuticals and DroneShield were among the top performing companies on the index

The Australian sharemarket ended the day stronger, lifted by widespread gains across regional markets and a positive tone in global equity futures. A temporary easing of import tariffs on electronics by the US government appeared to contribute to improved sentiment across the Asia-Pacific region.

The benchmark S&P/ASX 200 index recorded gains across most sectors, with all but one sector finishing in positive territory. Market activity was broadly upbeat, tracking closely with trends seen in overseas markets.

Sector Highlights

The technology sector was the strongest performer on the day. This upswing coincided with the announcement from the US administration, which temporarily delayed certain electronic trade restrictions. The move was perceived to be favourable for the global technology supply chain, with Australian tech shares responding positively.

Other major sectors, including financials, healthcare, and consumer discretionary, also contributed to the broader advance. The rise in the local currency against the US dollar was noted, with the Australian dollar strengthening during the session.

Key Company Developments

Neuren Pharmaceuticals saw significant share price appreciation after releasing an update on its development pipeline. The company stated that a recent interaction with the US Food and Drug Administration had been productive, with plans to move forward on a new clinical trial. This news was well received in the market, placing Neuren among the strongest gainers for the session.

DroneShield also posted strong gains following the announcement of new contract awards. The company disclosed that it had secured multiple repeat contracts with a military partner in the Asia-Pacific region. These contracts were said to be part of a growing demand for defence and surveillance technologies, particularly in regional security collaborations.

Changes in Company Ratings

Macquarie Group experienced a marginal decline during the session. This followed a revised rating by a financial institution, which expressed caution around the group’s earnings trajectory due to delays in global capital market recovery.

In contrast, Newmont Corporation recorded a noticeable uptick. The increase came after an international firm updated its gold price expectations, leading to a revised assessment of the company's valuation. A similar adjustment was made for Regis Resources, which also saw a revised stance in line with movements in the gold sector.

Currency Movement

The Australian dollar continued to strengthen against its US counterpart. Currency traders responded to broader market movements and global policy developments, with the local currency last trading higher during the session.

Overall Market Context

The upward movement in the ASX mirrored strength in regional markets and a positive backdrop for equities internationally. Sectors tied to technology and healthcare saw the greatest benefit, supported by macro-level developments and corporate updates. Activity on the local bourse remained aligned with external drivers, especially those linked to global trade and commodity pricing.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.